ARMC
AZN icon

American Research & Management Company’s AstraZeneca AZN Stock Holding History

American Research & Management Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$7K Hold
63
– – ﹤0.01% 302
2022
Q2 		$8K Buy
+63
New +$8.27K ﹤0.01% 299

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

American Research & Management Company's AZN Position: Q3 2022 in Review

American Research & Management Company held its AstraZeneca (AZN) position steady in Q3 2022 at 63 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

American Research & Management Company first reported a position in AZN in Q2 2022 and has held it in 2 quarters since. The position peaked at $8K in Q2 2022. 966 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • American Research & Management Company held 63 shares of AstraZeneca worth $7K as of Q3 2022.
  • American Research & Management Company left its AstraZeneca share count unchanged in Q3 2022.
  • AstraZeneca made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #302 holding.
  • American Research & Management Company first reported a position in AstraZeneca in Q2 2022 and has held it in 2 quarters since.
  • American Research & Management Company's AstraZeneca position peaked at $8K in Q2 2022.
  • 966 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.